Hektas Ticaret T.A.S.

Hektas Ticaret T.A.S.

BBIST:HEKTS
1.77
TRY
-0.06
(-3.28%)
-0.57EPS
27.82BMarket Cap
Hektas Ticaret T.A.S.
BIST:HEKTS
(Istanbul Exchange)

Recent

price

1.77

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TRY
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.05
0.05
0.43
0.69
2.66
1.24
1.85
0.73
0.77
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.08
0.11
0.31
-0.18
-1.04
-0.48
-0.57
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
-0.02
- -
-0.16
-0.37
-1.16
-0.02
1.35
0.1
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.04
0.07
0.17
1.18
1.55
2.14
1.66
1.95
Book Value per Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.04
0.05
0.13
1.03
0.86
1.89
1.39
1.66
Tangible Book Value per Share
10,478
10,478
10,478
10,478
10,478
10,478
10,478
10,478
10,478
15,660
2,337
2,927
3,755
7,038
3,435
8,430
8,430
Basic Weighted Avg Shares
85
102
117
113
139
161
177
252
497
733
1,014
2,021
10,001
8,719
6,371
6,128
6,491
Sales/Revenue/Turnover
17.68
16.7
19.61
18.89
18.37
20.5
21.48
24.72
35.88
34
22.87
24.83
20.21
-13.84
-58.63
-49.75
-37.42
Operating Margin (%)
1
2
2
2
2
3
3
4
5
14
28
53
337
788
1,081
1,168
1,194
Depreciation Expense
14
13
20
18
22
24
29
49
106
146
179
319
1,167
-1,268
-3,569
-4,046
-4,799
Net Income, GAAP
19.87
19.85
19.98
19.87
20.33
20.4
20.04
20.27
10.18
- -
- -
2.48
2.91
- -
- -
- -
- -
Effective Tax Rate (%)
16.98
12.62
16.99
15.96
16.02
15.03
16.6
19.52
21.36
19.87
17.62
15.81
11.66
-14.54
-56.02
-66.03
-73.94
Profit Margin (%)
69
70
77
77
82
83
112
89
205
580
311
170
1,663
-965
1,989
-5,503
-4,537
Working Capital
- -
- -
- -
- -
- -
- -
25
6
41
345
157
61
359
1,372
3,553
1,799
1,640
LT Debt
93
94
102
103
110
115
123
143
250
507
804
1,447
8,331
10,886
17,977
13,874
17,581
Total Equity
12.56
11.78
17.77
17.93
19.49
22.48
23.1
29.99
36.28
- -
- -
14.62
13.77
- -
- -
- -
- -
Return on Invested Capital (%)
20.73
11.66
19.09
17.05
19.08
19.56
23.5
30.81
38.76
- -
- -
18.94
27.6
- -
- -
- -
- -
Return on Capital (%)
16.15
13.75
20.38
17.6
20.9
21.55
24.57
36.97
54.12
38.46
27.58
28.8
23.93
-13.2
-24.68
-25.3
-30.71
Return on Common Equity (%)

Capital Structure

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
8,122
9,009
11,423
LT Borrowings
1,027
1,063
880
LT Finance Leases
772
777
761
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8,430
8,430
8,430
Market Capitalization
25,796
24,110
27,819

Working Capital

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
6,182
7,247
10,415
Cash, Cash Equivalents & STI
1,379
1,977
4,958
Accounts Receivable, Net
1,264
1,979
2,938
Inventories
2,485
2,130
1,774
Total Current Liabilities
11,686
12,436
14,952
Payables & Accruals
- -
- -
- -
ST Debt
8,122
9,009
11,423
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
88.8%
125.78%
-22.82%
Free Cash Flow
-154.48%
-729.31%
-81.62%
Net Income, GAAP
59.44%
66.03%
13.37%
Sales/Revenue/Turnover
68.58%
90.14%
-3.81%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,784
1,575
1,237
1,144
6,371
2025
2,734
1,972
975
1,168
6,128
2026
2,222
2,126
- -
- -
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.05
-0.13
-0.17
-0.09
-1.04
2025
-0.09
-0.1
-0.14
-0.19
-0.48
2026
-0.03
-0.22
- -
- -
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Hektas Ticaret T.A.S. is a Turkey-based company specializing in the production, import, and marketing of agricultural chemicals and veterinary products. Its core product portfolio includes over 250 plant protection and plant nutrition products such as fungicides, herbicides, insecticides, acaricides, biological insecticides, fumigants, nemathists, plant growth regulators, winter struggle medicines, summer oils, molluscicides, foliar fertilizers, organominerals, drip irrigation products, pure fertilizers, and seeds for tomato, cotton, and wheat. The company also offers animal health products including antibacterials, vitamins and minerals, feed additives, analogues, antiparasitic treatments, as well as pet food and pet care products. Hektas manages marketing and sales through regional offices across seven provinces in Turkey and operates factories in Gebze and Sanliurfa with substantial production capacity. Founded in 1956 and headquartered in Gebze, Turkey, Hektas serves agricultural producers primarily within Turkey and has expanding international exposure including activities in Australia and Uzbekistan. Recent major company developments include the acquisition of veterinary medicine producer Arma İlaç in 2021, expanding its animal health segment, and the establishment of a pet food production facility in Manyas, Balıkesir. Hektas also acquired 51% of Australian drought-resistant seed producer Agriventis and has pursued seed breeding activities through acquiring Areo Tohumculuk in Antalya. Additionally, the company invested in a subsidiary, Hektas Asia LLC, to expand its footprint in Uzbekistan. It continues strategic partnerships including memoranda of understanding with Pakistan’s Fauiji Foundation and Malaysia’s Boustead Holdings Berhad to foster collaboration and export growth. Hektas is noted for focusing on sustainable agricultural practices and smart agriculture solutions, aligning with its role as a pioneer in its sector. It is a subsidiary of OYAK Group and is listed on the Borsa Istanbul BIST 30 index.